Fusion event
HBV-GALNT2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TGTAAACAATACCTGAACCTTTACCCCGTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGG| |GCCATCAGCGCATGCGTGGAACCTTTTCGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACAT
End
230376983/230241237 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-101-1/Upstream/1779085; hsa-mir-1182/Downstream/778591;
Upstream sequence
ttataatagctgcttttaaatcctcccctgctaattccaacctctgggtcatctcagggtgaacttctgatgactttttttctctttgatgtggtctcca
Downstream sequence
ttttcctgtttcttctcatgtgtagtggttttttattttataattgacattgtggatgatatgttgtagaaacactggattatgttatctttctctaaag
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.